Wikidata

(Q65471335)

English

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

clinical trial

In more languages

Statements

title
A Multi-national, Open-labelled, Randomised, Parallel Group, 4 Week run-in and 26 Weeks Treat-to-target Comparison of Biphasic Insulin Aspart 30 Once Daily Versus Insulin Glargine Once Daily Both in Combination With Metformin and Glimepiride in Insulin naïve Subjects With Type 2 Diabetes (English)
0 references
country
Argentina
0 references
Austria
0 references
Czech Republic
0 references
France
0 references
India
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
Philippines
0 references
Poland
0 references
Romania
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
start time
May 2007
0 references
end time
April 2008
0 references
number of participants
480
0 references
research intervention
metformin
0 references
glimepiride
0 references
NPH insulin
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65471335&oldid=1858463411"